Project #86: Elucidation of the Regulatory Mechanisms of Naïve T Cells by Gut Microbial Metabolites for Therapeutic Strategies in T1D
This grant supports research into how gut microbial metabolites regulate naïve T cells to develop new therapeutic strategies for type 1 diabetes.
Funder: Diabetes Research Connection
Due Dates: Rolling
Funding Amounts: Up to $75,000 per project; typically supports early-stage, innovative T1D research.
Summary: Supports novel research into gut microbial metabolites' regulation of immune cells to develop new therapies for type 1 diabetes.
Key Information: Focused on early-career scientists and innovative, peer-reviewed T1D research.
Description
This opportunity from the Diabetes Research Connection funds research that explores how gut microbial metabolites—specifically, the postbiotic isoLCA—regulate naïve T cells and influence immune responses relevant to type 1 diabetes (T1D). The project aims to elucidate the mechanisms by which isoLCA modulates immune pathways, potentially leading to new therapeutic strategies for preventing or mitigating T1D onset by targeting immune cell activation at an early stage. The funder prioritizes innovative, peer-reviewed studies that advance the understanding and treatment of T1D.
